Lawmakers have expressed concern over a new form of alcohol that could hit the market as early as the fall. In early April, the Alcohol and Tobacco Tax and Trade Bureau (TTB) approved labels for seven varieties of Palcohol, a brand of dehydrated alcohol, ranging from straight vodka to a powdered margarita. Derided as “the Kool-Aid of teen binge drinking," lawmakers and other concerned parties say Palcohol poses a particular risk for youth who may be attracted to this easily portable, easily hidden form of alcohol.
Evaluation is different from any other element to the Strategic Prevention Framework. It is the single area where coalitions will pay for ongoing support typically contracted on a yearly basis. According to CADCA’s 2012 Annual Survey, almost two-thirds of coalitions use a paid evaluator to help them manage their ongoing evaluation efforts. However, it can be challenging trying to understand how an outside paid consultant fits into the coalition structure, what role this consultant should play in the coalition, and how much authority they should have regarding important decisions related to evaluation. To help coalitions navigate these challenges, CADCA will offer a webinar, entitled “Collaborating with Evaluators to Enhance Coalition Skills” on Thursday May 15 at 3 p.m. EST.
When teens are caught drinking or using marijuana at school, a trip to the dean's office may not suffice. These students also should be screened for exposure to trauma, mental health problems and other serious health risks, according to a study presented at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada. The study was reported in Medical News Today.
The Drug Enforcement Administration (DEA) and other federal, state, and local partners announced the culmination of Project Synergy Phase II, an ongoing effort targeting every level of the dangerous global synthetic designer drug market. Since January and leading up to this week, nationwide enforcement operations have taken place targeting these drug trafficking organizations that have operated in communities across the country.
May is Healthy Vision Month and provides a chance to educate your community about the health consequences of smoking on vision. Smoking is now known to cause age-related macular degeneration (AMD). Age-related macular degeneration, or AMD, is an eye disease that causes loss of vision in the center of the field of vision. It is the leading cause of vision loss in people over age 65. Smoking also causes cataracts, and both diseases are major causes of blindness. You can use this new infographic and messaging in your social media efforts, tweets and posts.
Too often what makes the news are stories of youth drug use. On Thursday, 1800 youth from Ohio held a rally in Columbus with the hopes that a different message would make the news – that the majority of teens don’t use drugs and alcohol.
The week of May 18-24, the Substance Abuse and Mental Health Services Administration (SAMHSA) will hold its third annual National Prevention Week, which brings together individuals, organizations, coalitions, states, and communities to raise awareness about substance abuse prevention and mental health.
A new study funded by the National Institute of Alcohol Abuse and Alcoholism (NIAAA) offers clues about how teen drinking alters brain chemistry, suggesting early alcohol use has long-term effects on decision making. The study was reported in Newswise.
“Marijuana use is not benign, and adolescents are especially vulnerable to its many known adverse effects,” the American Academy of Child and Adolescent Psychiatry (AACAP) said in a new policy statement. The AACAP goes on to say that it opposes efforts to legalize marijuana. The announcement was reported in Psychiatric News.
Make plans to attend a special no-cost Geographic Health Equity Alliance Symposium focusing on social change interventions impacting tobacco and cancer-related geographic health disparities. The symposium will be held at the Wyndham Grand Orlando Resort Bonnet Creek Hotel, Orlando, Florida on Friday, July 25th from 9:30 a.m. - 3:00 p.m. immediately following CADCA’s 2014 Mid-Year Training Institute. Preregistration is required.
Limiting the sale, display, and advertising of tobacco products should be a key part of any comprehensive tobacco control program. The new Point-of-Sale Strategies Tobacco Control Guide, a new publication developed by the Center for Public Health Systems Science at Washington University in St. Louis in partnership with the Tobacco Control Legal Consortium, helps coalitions do just that. The Guide provides practical guidance on selecting and implementing strategies to reduce exposure to tobacco products and advertising in stores.
The 3rd National Rx Drug Abuse Summit concluded today in Atlanta, Ga. Hosted by Operation UNITE, a Kentucky-based organization and CADCA member, the Rx Summit shines a spotlight on the epidemic of prescription drug abuse and identifies solutions. CADCA, a supporting partner of the Rx Summit, featured prominently at the three-day event, serving as a trainer of various sessions, facilitating panel discussions and showcasing various prescription drug abuse prevention resources.
Registration is open for CADCA’s 13th annual Mid-Year Training Institute scheduled for July 20-24, 2014 in Orlando, Fla. at the Hilton Orlando Bonnet Creek and Waldorf Astoria complex. The CADCA Mid-Year will feature a number of in-depth courses geared directly toward community coalitions with Drug Free Communities (DFC) funding. Stay tuned for a full listing of courses which will be posted on the Mid-Year website on May 5th!
As part of its implementation of the Family Smoking Prevention and Tobacco Control Act signed by the President in 2009, the U.S. Food and Drug Administration today proposed a new rule that would extend the agency’s tobacco authority to cover products such as e-cigarettes, hookahs, cigars and other tobacco products that are currently unregulated.
A national response to the epidemic of prescription opioid overdose deaths was outlined this week in the New England Journal of Medicine by leaders of agencies in the U.S. Department of Health and Human Services. The commentary calls upon health care providers to expand their use of medications to treat opioid addiction and reduce overdose deaths, and describes a number of misperceptions that have limited access to these potentially life-saving medications. The commentary also discusses how medications can be used in combination with behavior therapies to help drug users recover and remain drug-free, and use of data-driven tracking to monitor program progress.